naltrexone
The Fix examines the medical, moral and monetary decisions that Alkermes made to bring its drug Vivitrol to market—including a controversial trial in Russia. Are the critics right to cry foul? MORE
Problem gamblers will be the subject of an upcoming trial of the "anti-addiction" drug Naltrexone. MORE
The field of addiction has to get it together. This modest proposal offers five places to start, from individualizing treatment to professionalizing treaters. MORE
Medical intervention can dramatically increase recovery success rates. But without an attitude adjustment in the rooms and most rehabs, new and better drugs will remain elusive. MORE
Combining buprenorphine with naltrexone produces highly promising results in a rat study. MORE
If addiction is a medical disease, why have we abandoned it to untrained counselors, unproven treatments and unaccountable programs? MORE
A rehab president tells The Fix that Rx pain meds and Mexican cartels are to blame. MORE
Brain imaging revealed two big firsts about addiction. But how "big" and "first" were they really? MORE
Trouble for female alcoholics, new anti-craving drugs, a rise in caffeine addiction, and other medical news. MORE
By Dirk Hanson
Experts slam treatment centers for withholding anti-craving pills from patients. MORE








